Thursday Roundup: Markets struggle to rise; All eyes on balance sheets and bonds; What to watch for

April 21, 2022 By: WealthMintr Team

In Europe, stocks have been positive since opening; S&P and Dow futures struggle to stay positive, but Nasdaq contracts surrender to Netflix crash North American markets, whose tone had deteriorated since yesterday’s close, are struggling to position themselves in the positive field. But the results of Netflix, whose shares fell as much as 27% before the stock market opened, cooled the...

Continue reading >>

Tuesday’s Top Gainers; Checkmate Pharmaceuticals, Axsome Therapeutics, & Super Micro Computer

By: WealthMintr Team

CHECKMATE UP 329% FOLLOWING ACQUISITION PROPOSAL  Checkmate Pharmaceuticals (NASDAQ: CMPI) shares were up 329% in response to a $250 million buyout proposal from Regeneron Pharmaceuticals (NASDAQ: REGN). Regeneron is looking to acquire Checkmate in an all-cash deal of $10.5 per share, representing a 332% premium from where Checkmate Pharmaceuticals’ shares closed on Monday. The companies...

Continue reading >>

Wednesday Roundup: US and European markets rebound

April 13, 2022 By: WealthMintr Team

US AND EUROPEAN MARKETS REBOUND FOLLOWING ROUGH PATCH Global markets are dealing with a series of challenges. Escalating war in Ukraine, balance sheet season, and macroeconomic indicators, especially inflation. However, following three consecutive red days on Wall Street, bargain hunters may be tempted to take action. US index futures are gaining traction, with mining and energy companies...

Continue reading >>

Friday’s Top Losers; C4 Therapeutics, BioCryst, & Zentalis

April 11, 2022 By: WealthMintr Team

C4 THERAPEUTICS ANNOUNCES CFT7445 STUDY RESULTS  C4 Therapeutics Inc. (NASDAQ: CCCC) dropped 50.57% after announcing Cohort A from the ongoing Phase 1/2 clinical study of CFT7455, a proprietary degrader that targets IKZF1/3 for non-Hodgkin’s lymphomas and multiple myeloma. The company has learned a lot from only five melanoma patients in the study’s first cohort. Now, C4 Therapeutics Knows...

Continue reading >>

Weekend Roundup: Markets up despite new sanctions against Russia; Russia surprises with interest rate cut; What to watch for

By: WealthMintr Team

US index futures and European markets rise, and bond premiums get more expensive; investors watchful for developments in the Russia-Ukraine war MARKETS UP DESPITE NEW SANCTIONS AGAINST RUSSIA After a week of intense swinging in the stock markets, the markets seem to want to recover from the losses accumulated in the period. Despite the tumultuous news, with the escalation of the war and a new...

Continue reading >>

Tuesday’s Top Gainers: Spirit Airlines, System1 & Black Knight

April 7, 2022 By: WealthMintr Team

SPIRIT AIRLINES JUMPS AFTER A $3.6 BILLION OFFER FROM JETBLUE AIRWAYS Spirit Airlines Inc. (NYSE: SAVE) was up 22.42% after JetBlue Airways made an all-cash offer of $3.6 billion for the company, which has raised questions regarding Spirit’s deal to merge with Frontier Airlines. The company indicated that its Board is evaluating the offer from JetBlue and will take an appropriate course of...

Continue reading >>